home
General
Barretts Esophagus
H Pylori
UGIB
LGIB
Occult Bleeding
Acute Pancreatitis
Chronic Pancreatitis
IBD
IBS
Hepatitis
Hepatic Failure
Ascites
 

Fellowship Program Home

 

Contact Us

703 19th Street South Zeigler Research Bldg Room 633  Birmingham, AL 35294

Phone: 205-934-6060 Fax:       205-934-8493

 

  
 
  
 
The University of Alabama at Birmingham
Department of Medicine

Division of Gastroenterology and Hepatology

 

IBD

 


5-ASA:

Dissanayake S. Long-term maintenance with sulphasalazine in UC

Steroids:

Adachi JD. Intermittent Etidronate therapy

Ardizzone S. Azathioprine in Steroid-Resistant and Steroid

Brignola C. Steroid treatment in Crohn's

Cortot A. Switch from systemic steroids to budesonide in st

Faubion W. The Natural History of Corticosteroid Therapy for IBD

Greenberg G. Oral budesonide for active crohn's disease

Rutgeerts P. A comparison of budesonide with prednisolone f

Azathioprine/6-MP:

Candy S. A controlled double blind study of azathioprine in

Dubinsky M. Pharmacogenomics and Metabolite Measurement for

Ewe K. Azathioprine Combined With Prednisolone or monothera

Falasco G. Immunosuppressants in distal ulcerative colitis

George J. The Long-Term Outcome of Ulcerative Colitis Treat

Hawthorne A. Randomised Controlled Trial of Azathioprine Wi

Lauritsen K. Longterm olsalazine treatment

Lennard L. Clin Pharmacol of 6-MP

O'Donoghue. Double-blind trial of azathioprine in Crohn 's

Present D. Treatment of Crohn's Disease With 6-MP

Methotrexate:

Feagan B. A Comparison of Methotrexate With Placebo for the

Feagan B. Methotrexate for the Treatment of Crohn's Disease

Kozarek R. Methotrexate Induces Clinical and Histologic Rem

Lemann M. Methotrexate in Crohn's

Cyclosporine:

D'Haens G. IV cyclosporine vs IV steroids

Lichtiger S. Cyclosporine in UC

Sandborn W. Tacrolimus for the Treatment of Fistulas in Pat

Biologics:

Chey W. Infliximab in UC

Ghosh S. Natalizumab for Active Crohn's Disease

Hanauer S. Maintenance infliximab for Crohn's disease- the

Keane J. Tuberculosis Associated with Infliximab a Tumor Ne

Present D. Infliximab for the Treatment of Fistulas in Pati

Reddy P. Infliximab (Remicade)

Rutgeerts P. Efficacy and safety of Infliximab in CD

Sandborn W. An engineered TNF antibody CDP571

Sandborn W. Biologic Therapy of IBD

Sands B. Infliximab Maintenance Therapy for Fistulizing Cro

Targan S. A short-term study of chimeric monoclonal antibody cA2

Other:

Abreu M. Use of Serologic Tests in Crohn's Disease

Askling J. Family history as risk factor in IBD

Bernstein C. Cancer Risk in Patients with IBD

Brandt LJ. Metronidazole for perineal Crohn's

Cottone M. Smoking Habits and Recurrence in Crohn's Disease

D'Haens G. Patchy Cecal Inflammation Associated with Distal

Hanauer S. Management of Crohn's disease in adults

Itzkowitz S. Cancer prevention in patients with inflammator

Modigliani R. Clinical Biological and Endoscopic Picture of

Rutgeerts P. Natural history of Crohn's

Seidner D. An Oral Supplement Enriched With Fish Oil and So

Stoffel EM. Osteoporosis in IBD

Tremaine W. A prospective cohort study

Tremaine WJ. Practice guidelines for IBD

Antibiotics:

Bernstein L. Healing of Perineal Crohn's Disease with Metro